U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06911190) titled 'Ten Year Follow-up in FSHD: the FOCUS 3 Study' on March 21.
Brief Summary: This study aims to assess longitudinal data in 170 adult and 30 pediatric genetically and clinically well-defined facioscapulohumeral dystrophy (FSHD) patients. FSHD is a chronic progressive disorder associated with major disability due to loss of function and independence. The clinical variability of FSHD is partially explained by currently known (epi)genetic factors. Identifying the variables that influence the clinical variability is essential for developing targeted therapies. Furthermore, it is crucial to assess the natural course, determine sensitive ou...